Compare
MRNA vs SPY
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| MRNA | SPY | |
|---|---|---|
| Price | $254.19 | $735.29 |
| 1-day | +5.27% | +0.31% |
| YTD | +761.95% | +7.83% |
| 1 year | +978.90% | +8.52% |
| 3 years | +233.58% | +73.97% |
| Market cap | $102.8B | — |
| P/E | — | — |
| P/S | 40.73 | — |
| P/B | 15.04 | — |
| Revenue growth | +13.10% | — |
| EPS growth | — | — |
| Gross margin % | 28.0 | — |
| Net margin % | -110.5 | — |
| ROE % | -40.8 | — |
| Debt / equity | 0.09 | — |
| FCF yield % | -1.9 | — |
| Dividend yield % | — | — |
| Beta | 2.27 | 1.00 |
| RSI (14) | 63.7 | 35.1 |
| Technical rating |